Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing neovascular age-related macular degeneration (nAMD) in older patients with diabetes, ...
Anti–vascular endothelial growth factor (VEGF) treatment was associated with preserved useful visual acuity in almost 20% of patients with neovascular age-related macular degeneration (nAMD). In ...
Managed care professionals play a significant role in the management of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) through formulary management and drug ...
MedPage Today on MSN
More evidence that GLP-1s may reduce risk of vision-robbing eye diseases
Significantly lower AMD risk compared with other agents in cohort study ...
New research examined the effects of cataract surgery on visual acuity and disease activity in patients with nAMD receiving anti-VEGF treatment. The treatment intensity for underlying nAMD remained ...
Please provide your email address to receive an email when new articles are posted on . Contrary to expectations, more patients with neovascular age-related macular degeneration undergoing longer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results